Contract Service Directory

Quotient Sciences





Company Headquarters

3080 McCann Farm Drive
Garnet Valley, PA 19060
United States

Contract Service Directory

    Content From Quotient Sciences

    Related Content

    • Breaking News | Clinical Trial Materials | Collaborations & Alliances | Industry News
      ANA Therapeutics Partners with Quotient Sciences

      ANA Therapeutics Partners with Quotient Sciences

      Will manufacture ANA001 as a potential treatment for COVID-19.
      Contract Pharma Staff 08.13.20

    • Breaking News | Collaborations & Alliances | Industry News
      Quotient Sciences, CytoAgents Form COVID-19 Collaboration

      Quotient Sciences, CytoAgents Form COVID-19 Collaboration

      Expedites human clinical trials for COVID-19 drug candidate
      Contract Pharma Staff 05.04.20

    • Tufts CSDD Study on Accelerating Drug Development

      Tufts CSDD Study on Accelerating Drug Development

      Download this white paper to discover the time savings and financial benefits for drug developers that use Translational Pharmaceutics®.


    • Breaking News | cGMP Manufacture | Formulation Development | Industry News
      Tufts Study Shows Translational Pharmaceutics Reduces Development Times

      Tufts Study Shows Translational Pharmaceutics Reduces Development Times

      Can reduce development times by more than 12 months and lower R&D costs by more than $100 million per approved new drug.
      10.31.19

    • AAPS Exhibitor List

      ...
      10.29.19

    • cGMP Manufacture | Formulation Development | Industry News
      Permira Funds to Acquire Majority Stake in Quotient

      Permira Funds to Acquire Majority Stake in Quotient

      Investment will support Quotient’s growth plans to expand formulation development and manufacturing capabilities
      07.18.19


    • Breaking News | cGMP Manufacture | Drug Development | Facilities | Formulation Development | Industry News
      Quotient Sciences Invests $15M in New Facility

      Quotient Sciences Invests $15M in New Facility

      Constructs state-of-the-art early-phase formulation and manufacturing facility in U.S.
      10.16.18

    • cGMP Manufacture | Clinical Trial Materials | Clinical Trials | Drug Development
      Integrating CDMO and CRO Services

      Integrating CDMO and CRO Services

      Mark Egerton explains the importance of integrating formulation development and adaptive manufacturing with clinical research
      Kristin Brooks, Managing Editor 09.04.18

    • Drug Development
      Integrated Early-Stage Drug Development and Manufacturing

      Integrated Early-Stage Drug Development and Manufacturing

      A key to accelerating the drug development process.
      Mark Egerton, Chief Executive Officer, Quotient Sciences 03.09.18


    • Breaking News | cGMP Manufacture | Clinical Trial Materials | Clinical Trials | CRO News | Drug Development | Industry News
      PPD, Quotient Sciences Form Pediatric Drug Pact

      PPD, Quotient Sciences Form Pediatric Drug Pact

      Aims to accelerate pediatric drug development by shortening timelines, reducing costs and simplifying contracting processes
      01.16.18

    • Drug Development
      Photos from the 2017 AAPS Annual Meeting

      Photos from the 2017 AAPS Annual Meeting

      The show floor exhibition, Quotient unveiling, and Steer Life product premier
      11.21.17

    • Breaking News | Industry News
      Quotient Sciences Expands UK Footprint

      Quotient Sciences Expands UK Footprint

      Acquires UK-based CDMO Pharmaterials
      11.17.17


    • Breaking News | Industry News
      Quotient Sciences Acquires CDMO Pharmaterials

      Quotient Sciences Acquires CDMO Pharmaterials

      The move further expands Quotient’s footprint in the U.K.
      11.14.17

    • cGMP Manufacture | Clinical Trial Materials | Drug Development | Formulation Development | Industry News
      Quotient Clinical Launches New Identity

      Quotient Clinical Launches New Identity

      New identity depicts extended range of services following acquisitions of Co-Formulate, QS Pharma and SeaView Research
      11.10.17